Prior to joining HEP 12 years ago, Dave was a Vice President for Susquehanna Growth Equity, a private equity group focused on growth stage technology companies. He was formerly the President and Chief Operating Officer of Onward Healthcare, Inc., a Welsh, Carson, Anderson & Stowe portfolio company. Prior to Onward, Dave was an Executive Vice President of Pinnacor, Inc., a General Atlantic portfolio company, which went public.
Dave is currently on the board of directors of Bardy Diagnostics, Catapult Health, Intraprise Health, Jet Health, NOCD and Payer Compass. Dave previously served on the board of directors for Access Physicians (acquired by SOC Telemed), eVariant, (acquired by HealthGrades), HealthQx (acquired by McKesson), MobileMD (acquired by Siemens Healthcare), Nordic Consulting (recapitalized by Silversmith Capital Partners), Privia Health (merged with Brighton Health), Shyft Analytics (acquired by Medidata) and Vitals.
He is on the faculty at Columbia Business School. In addition, Dave is also a member of the Healthcare Initiative Advisory Board at Harvard Business School. Dave is a distinguished graduate of the United States Military Academy and holds an MBA from Harvard Business School.